Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrophilic Methacrylate Gel Versus Beta-Sitosterol Ointment for Early Cesarean Scar Healing
NCT07547462Completed
- Sponsor
- Hamad Medical Corporation
- Start
- Dec 2023
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Hamad Medical Corporation. Primary endpoint: Scar Redness (Vascularity) Assessed by Vancouver Scar Scale (VSS) at Day 12. Started Dec 2023; status: completed.
Beyond the preview
Go deeper on NCT07547462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07547462.